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A B S T R A C T
A large number of catalytic RNAs, or ribozymes, have been identiﬁed in the genomes of various organisms and
viruses. Ribozymes are involved in biological processes such as regulation of gene expression and viral re-
plication, but biological roles of many ribozymes still remain unknown. Ribozymes have also inspired re-
searchers to engineer synthetic ribozymes that function as sensors or gene switches. To gain deeper under-
standing of the sequence-function relationship of ribozymes and to eﬃciently engineer synthetic ribozymes, a
large number of ribozyme variants need to be examined which was limited to hundreds of sequences by Sanger
sequencing. The advent of high-throughput sequencing technologies, however, has allowed us to sequence
millions of ribozyme sequences at low cost. This review focuses on the recent applications of high-throughput
sequencing to both characterize and engineer ribozymes, to highlight how the large-scale sequence data can
advance ribozyme research and engineering.
1. Introduction
Since the ﬁrst discoveries of ribozymes by Cech [1] and Altman [2],
several classes of ribozymes have been found in various organisms and
viruses. While the sequences and structures of these ribozymes are
highly diverse, the majority of the naturally occurring ribozymes are
involved in either splicing or self-cleavage of RNA strands. However, in
vitro selection experiments from a large pool of random RNA sequences
have resulted in ribozymes capable of catalyzing various chemical re-
actions beyond nucleic acid chemistry such as Diels-Alder [3] and aldol
[4] reactions, underscoring the latent potential of ribozymes to catalyze
diverse reactions. Regardless of the origins of the ribozymes, elucida-
tion of the sequence-function relationship is of fundamental importance
for understanding and engineering ribozymes. Conventional mutational
analysis of a ribozyme involves preparation of individual ribozyme
mutants followed by biochemical assay of their activities, for example,
by gel electrophoresis. Single-base substitutions (single mutants) that
compromise activity indicate that those nucleotides are critical for ri-
bozyme function (and possibly structure). Base pairs that are func-
tionally important can be conﬁrmed by single mutants that disrupt the
suspected base pair (inactive ribozyme) and double mutants that re-
place the original base pair with an alternative pair (active ribozyme).
While such classical biochemical assays provide quantitative ribozyme
activity information for the mutants examined, the number of ribozyme
variants that can be characterized is limited. Therefore, mutants that
are subjected to conventional mutational analysis are highly biased by
the researcher.
2. Mutate, select, and sequence
Because RNA can be readily ampliﬁed by reverse transcription and
polymerase chain reaction (PCR), ribozymes can be selected for activity
in vitro. In fact, most artiﬁcial ribozymes have been selected from
random RNA sequences through iterative selection cycles [5]. The
prime advantage of ribozyme selection is its ability to enrich higher
activity sequences from a large number (up to ∼1015) of sequences.
Therefore, by starting from a pool of mutants of a ribozyme of interest
instead of a random pool of sequences, in vitro selection can isolate only
those mutants that retain a certain level of activity and eliminate those
with weaker or no activity. Sequence analysis of the mutants that sur-
vive the selection should provide rich information on sequence-function
relationship of the parental ribozyme. Ribozyme mutants can be pre-
pared either by “doped” oligonucleotide synthesis or error-prone PCR.
In doped oligonucleotide synthesis, the template DNA for in vitro
transcription of a ribozyme is synthesized with a mixture of the wild-
type nucleotide monomer doped with small amounts (e.g. 3% each) of
three other monomers during the coupling steps. This results in a pool
of statistically mutated DNA (and thus RNA). By varying the doping
ratio, the researcher can control the composition of the mutants in the
library relatively well. Error-prone PCR employs manganese (II) ion or
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engineered DNA polymerase to elevate the error rate during PCR [6,7].
While error-prone PCR can introduce errors in long DNA sequences, it is
diﬃcult to control the error rate and the mutational spectrum is known
to be highly biased.
In the mutate-select-and-sequence strategy (Fig. 1), the goal of the
selection is to recover the mutants that retain some level of activity (e.g.
near wild-type) rather than to isolate the few sequences with the
highest activities. By analyzing which base-substitutions survive the
selection or not, functionally critical nucleotides for every position in
the ribozyme can be inferred. Furthermore, covarying mutations can be
identiﬁed from the sequencing data to discover base-base interactions
that are functionally critical. Earlier studies have used Sanger sequen-
cing of up to ∼100 mutants to infer such functionally important nu-
cleotides and base-base interactions. For example, Nehdi and Perreault
randomized 25 positions in the antigenomic HDV ribozyme and se-
quenced active variants that survived in vitro selection to identify
functionally critical bases and base pairs [8]. Curtis and Bartel studied
mutational coupling eﬀects of a large number of mutations in a kinase
ribozyme to characterize the ﬁtness landscape by Sanger sequencing
[9]. Fitness landscape is a conceptual map of genotype (ribozyme se-
quence) to ﬁtness (ribozyme activity) and its feature or “shape” is im-
portant for understanding the evolutionary processes.
While these eﬀorts have yielded useful insights, the amount of data
generated by Sanger sequencing severely limits the coverage of mutants
that exist in the selected ribozyme populations. Naturally, high-
throughput sequencing of the selected ribozymes guarantees more
comprehensive coverage of mutants with fewer base substitutions (e.g.
single and double mutants), therefore, can extract much richer se-
quence-function relationship information from selection experiments.
In a recent example, Hayden et al. selected active Azoarcus group I
ribozyme mutants under high and low Mg2+ concentrations and used
high-throughput sequencing to analyze the ribozyme populations that
survived the selections. As low Mg2+ is unfavorable for ribozyme
folding and activity, they identiﬁed and analyzed mutants that retain
activity at high Mg2+ concentration but lose activity at low Mg2+
concentration, and discovered that such mutations are localized to the
so called scaﬀold domain [10].
Similarly, high-throughput sequencing can be a powerful tool for
analyzing the global ﬁtness landscape and the evolutionary dynamics of
ribozymes evolved in the laboratory. This was ﬁrst demonstrated by Pitt
and Ferré-D'Amaré who selected for active mutants of the class II ligase
ribozyme [11] and sequenced the selected genotypes [12]. The re-
searchers used genotype abundance in the selected populations as a
proxy for biochemical activity to infer the ﬁtness landscape of the ri-
bozyme. The ﬁtness landscape surrounding the ribozyme sequence was
found to be rugged, meaning that minor mutations can drastically
change the ribozyme activity. In another example, Hayden et al.
demonstrated that cryptic mutations in the Azoarcus group I ribozyme
that accumulate during purifying selection can be advantageous for the
population to adapt to a new substrate by deep sequencing of the ri-
bozyme populations evolved in vitro [13].
In a complementary approach, Jäschke and coworkers studied how
ribozymes that catalyze Diels-Alder reaction emerged from random
sequences via in vitro selection [14]. They sampled and sequenced RNA
populations from diﬀerent stages of the multi-round in vitro selection
process, and found that the populations retain signiﬁcant diversity even
after ten rounds of selection. Similarly, Pressman et al. used high-
throughput sequencing to analyze RNA populations from an in vitro
evolution experiment of triphosphorylating ribozymes from a random
pool [15]. They used the sequencing data to estimate the distribution of
catalytic activity in the global RNA sequence space.
3. Mutate and sequence (without selection)
Mutate-select-and-sequence strategy exploiting high-throughput
sequencing allows comprehensive mutational analysis throughout the
ribozyme sequence which is impossible with conventional biochemical
analysis of individual mutants. However, there are few drawbacks that
should be considered. First, there are no quantitative information on
the relative activities of individual mutants. It should be noted that
abundance of individual mutants in the sequenced population does not
necessarily reﬂect their relative ribozyme activity [16]. As the starting
ribozyme population prepared by doped oligonucleotide synthesis or
error-prone PCR is already biased before selection, it can easily be
imagined that the selected population carries such biases as well. Fur-
thermore, the composition of the selected ribozyme population can also
depend on the stringency of the selection and any systematic biases
introduced during the selection process (reverse transcription and
PCR). Consequently, observation of mutations that survive a selection
experiment should be interpreted as a qualitative indication that such
mutations do not perturb activity below an arbitrarily set threshold
based on the applied selection pressure.
We recognized the limitations of the conventional biochemical
mutational analysis and the mutate-select-and-sequence strategy.
Therefore, we decided to develop a new high-throughput and quanti-
tative mutational analysis strategy for ribozymes. Focusing on self-
cleaving ribozymes, the overall strategy is summarized in Fig. 2. First, a
dsDNA library that contains all mutants of interest is synthesized by an
appropriate method. Second, the ribozyme library is generated by in
vitro transcription and allowed to undergo self-cleavage. The cleaved
and uncleaved fragments are converted into dsDNA via reverse tran-
scription and PCR while adding adapter sequences for high-throughput
sequencing. Finally, the dsDNA library is sequenced, and the number of
cleaved (Nclv) and uncleaved (Nunc) fragments for every mutant of
Fig. 1. Mutate-select-and-sequence (top) and mutate-and-sequence (bottom) strategies for high-throughput mutational analysis of ribozymes. In the mutate-select-
and-sequence approach, sequences of a very small fraction of the mutants that survive the selection (thus are active) are obtained, and abundance of each sequence
provides limited and qualitative information about the activity of such mutants. In the mutate-and-sequence approach, quantitative activity (e.g. fraction cleaved) is
calculated for a large number (103–106) of mutants regardless of their activity.
Y. Yokobayashi Methods 161 (2019) 41–45
42
interest are counted. Activity of each mutant can be calculated as
fraction cleaved (FC) as follows:
= +N N NFC /( )clv clv unc
The number of mutants that can be analyzed is limited by the
number of sequencing reads. Assuming a conservative average of 500
reads per mutant (Nclv+Nunc), a typical MiSeq output of 2× 107 reads
are suﬃcient for 4×104 mutants. Using a current state-of-the-art se-
quencer (e.g. NovaSeq 6000) that can generate up to 1010 reads per
experiment, as many as 2×107 mutants should be amenable to
quantitative analysis.
3.1. Mutational analysis of ribozymes
An important distinction of this sequencing-based analysis from the
mutate-select-and-sequence strategy is the lack of selection step which
can be time consuming and is intrinsically a biased process.
Furthermore, it provides quantitative activity (FC) for every mutant of
interest in the library (> 104) comparable to the results that would be
generated by biochemical assays of individual mutants (e.g. by gel
electrophoresis). The number of mutants that can be analyzed (> 104)
is also suﬃcient to cover all single and double mutants of a small ri-
bozyme. This was demonstrated by analyzing all single and double
mutants (10,296 mutants) within a 48-nt stretch of a small self-cleaving
ribozyme (Osa-1–4 twister ribozyme) [17]. The exhaustive and quan-
titative mutational analysis provided a number of interesting observa-
tions. For example, while there are 10 bases that are phylogenetically
conserved in 97% or more of the twister ribozymes, only two of them
were found to be invariable for retaining residual activity. Additionally,
global mutational analysis of single and double mutants revealed that
some structural elements were more robust against mutations than
others. The exhaustive mutational analysis data allowed another group
to evaluate the extent of epistatic interactions of mutations and it was
concluded that negative epistasis dominate in this ribozyme and other
small noncoding RNAs [18].
The results of the mutational analysis, however, represent “end-
point” ribozyme assays, and do not provide detailed kinetic constants
for each mutant. In theory, the ribozyme library can be reacted and
sampled at multiple time points to acquire kinetic data. While it has not
yet been applied to ribozymes, we recently reported parallel kinetic
analysis of a self-cleaving deoxyribozyme based on the method. In this
work, rate constants of 533 active mutants were obtained by ﬁtting the
time course data to a ﬁrst-order rate law. The rate constants were then
used to calculate activation energies using the Arrhenius equation [19].
This further allowed us to quantitatively assess the epistatic nature of
105 double mutants based on the activation energies of the corre-
sponding single mutants.
3.2. Engineering ribozymes
Mutate-and-sequence approach was also used to engineer ribozymes
for synthetic biology applications. An aptazyme is a ribozyme fused
with an RNA aptamer that can speciﬁcally bind to a target ligand (e.g.
small molecule or protein). It has been shown that insertion of an ap-
tazyme in the 3′ UTR of an mRNA enables chemical regulation of gene
expression by the aptamer ligand in eukaryotic cells [20]. Self-cleavage
of an aptazyme in the 3′ UTR detaches the poly(A) sequence resulting in
mRNA destabilization and translation repression. Aptazymes are typi-
cally constructed by inserting an aptamer in a structurally essential
stem loop of a ribozyme via a “communication module” that couples
ligand binding and ribozyme activity either positively or negatively.
Some communication modules have been designed rationally or
through trial-and-error, as well as through various screening or selec-
tion platforms. Rational or iterative design and test cycles have yielded
functional aptazymes, but it is a time-consuming and laborious process,
success is not guaranteed, and the sequence space that can be experi-
mentally tested is very limited.
The majority of the aptazyme engineering eﬀorts have relied on
some forms of screening or selection from a large pool of aptazyme
candidates with randomized communication module. A variety of se-
lection and screening methods exist for discovery of genetic switches in
bacteria and yeast, some of which has been used to screen functional
aptazymes in these organisms [21]. While these methods allow sam-
pling of a larger sequence space, they are laborious and time-consuming
to implement, often requiring several rounds of screening or selection.
Moreover, sequences are typically obtained only for very few “hits”,
and vast majority of the mutants generated for screening or selection
are simply discarded.
We applied the mutate-and-sequence approach described above to
assay 512 aptazyme mutants in which the nucleotides connecting the
guanine aptamer and an HDV-like ribozyme were randomized [22]. The
mutants were in vitro transcribed from a mixture of DNA templates with
or without guanine, and then converted to a sequencing library. “Bar-
code” sequences that distinguish the reaction conditions (with or
without guanine) were included in the reverse transcription primers.
This allowed us to calculate FC values of all mutants in the presence and
absence of guanine, regardless of their performance as switches. Not
only could best switch candidates be identiﬁed from the results, per-
formance of many of their mutants could also be accessed without
additional experiments. For example, we could quickly conﬁrm that
stabilizing the stem region connecting the aptamer and the ribozyme
generally increases the ribozyme activity (regardless of presence or
absence of guanine), and destabilizing the stem region generally ren-
ders the ribozyme less active (even in the presence of guanine). Such
analysis facilitates researchers to generate mechanistic hypotheses of
aptazymes. The guanine aptazymes identiﬁed were then shown to
function as riboswitches in mammalian cells.
Fig. 2. High-throughput ribozyme self-cleavage assay by sequencing. Ribozyme mutants are transcribed in vitro from DNA templates as a mixture. The ribozyme
mutants are then converted to dsDNA templates for high-throughput sequencing via reverse transcription and PCR during which adapter and barcode sequences are
attached. Sequencing allows the researcher to count the numbers of cleaved and uncleaved reads for each mutant in the library.
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In another example, we devised a tandem aptazyme architecture in
which an aptamer sequence is fused directly upstream (5′ end) of a
ribozyme so that the two structures are formed exclusively (Fig. 3A). It
was envisioned that the strength of the P1 stem of the aptamer plays a
key role in the performance of the aptazyme. If P1 is too strong, ribo-
zyme would be inactive even without the aptamer ligand. On the other
hand, if P1 is too unstable, aptazyme would be active even in the
presence of the aptamer ligand. Therefore, it was anticipated that when
the stability of P1 stability is optimally adjusted, the ribozyme would be
active without the ligand but would be inactive in its presence. This
system was implemented by fusing the guanine aptamer with a pistol
ribozyme, and randomizing seven bases upstream of the aptamer that
could potentially constitute the P1 stem, resulting in 16,384 aptazyme
mutants [23]. Analysis of the results allowed us to extract speciﬁc se-
quence requirements for aptazyme function. In another study, three
base pairs in the P4 stem adjacent to the catalytic site of an HDV-like
ribozyme was exhaustively mutated and analyzed to understand how
the stem stability aﬀects ribozyme activity (Fig. 3B) [24]. A number of
ribozyme mutants with varying activities were then inserted into the 3′
UTR of a reporter gene mRNA to ﬁne tune gene expression level.
Finally, the mutate-and-sequence approach was implemented in
mammalian cells. It has been pointed out that ribozyme and aptazyme
activities are often context dependent, for example, where the ribozyme
is inserted, or the cell type in which the ribozyme is used [25].
Therefore, it is desirable to perform high-throughput assay in the cells
in which the ribozyme is intended to be used. We observed that the
pistol ribozyme we used in a previous study did not self-cleave eﬃ-
ciently in mammalian cells even though it was highly active in vitro
[23]. Therefore, we decided to assay 376 natural pistol ribozyme var-
iants that have been computationally identiﬁed by the Breaker group
[26] for activity in mammalian cells. Additionally, we designed 2625
artiﬁcial pistol ribozyme mutants by recombining structural elements
(stems, linker, pseudoknot) of naturally occurring ribozymes in silico.
Total of 3001 pistol ribozyme sequences were synthesized by on-chip
parallel DNA synthesis and fused to U6 promoter by PCR. The linear
ribozyme transcription template was tranfected into HEK 293 cells, and
total RNA was extracted after 6 h. The total RNA was separated by gel
electrophoresis, and the regions that correspond to cleaved and un-
cleaved ribozymes were isolated and sequenced. This allowed us to
identify the ﬁrst pistol ribozymes demonstrated to be active in mam-
malian cells [27].
An alternative strategy for assaying and engineering ribozyme ac-
tivity in living cells was reported by the Smolke group. Townshend
et al. constructed aptazyme libraries in Saccharomyces cerevisiae by in-
serting aptazyme variants in the 3′ UTR of EGFP mRNA [28]. The cells
were then sorted in bins according to their EGFP expression level. By
analyzing the frequencies of each variant in the sorted populations by
high-throughput sequencing, they were able to identify intracellularly
functional aptazymes which were subsequently validated individually.
This sort-seq approach may allow rapid and direct identiﬁcation of
aptazymes that are functional in living cells.
3.3. Experimental considerations
The mutate-and-sequence strategy is still evolving and there are
several important experimental or technical points to be considered for
successful implementation. Ribozyme library can be constructed by
several methods. If the desired mutations are localized such as in the
case of aptazyme engineering, degenerate oligonucleotides can be
synthesized with randomized bases. It is highly recommended to use
“hand-mixed” bases for the randomized positions because standard
“machine-mixed” bases often result in highly biased base compositions.
If the desired mutations are spread over a long stretch of sequence as in
the case of mutational analysis of a ribozyme, doped oligonucleotide
synthesis can be used. This requires careful adjustment of the doping
ratio of each nucleotide to maximize the representation of the desired
set of mutants. Alternatively, on-chip parallel synthesis of up to ∼105
sequences oﬀers a more ﬂexible option to synthesize arbitrary se-
quences as a mixture. Unlike doped oligonucleotides, on-chip synthesis
allows each mutant to be represented approximately equally. However,
on-chip synthesis is costly and suﬀers high synthetic errors. Another
important limitation is that all mutations must reside in the same
fragment of the cleaved products.
High-throughput sequencing requires the sequencing template to be
ﬂanked by adapter sequences for cluster ampliﬁcation and for binding
of sequencing primers. The ﬁrst step in converting the ribozyme reac-
tion products to sequencing templates is reverse transcription. The re-
verse transcription primer, therefore, must bind to a constant 3′ se-
quence of both cleaved and uncleaved ribozymes which also must be
downstream of any mutations that must be sequenced. The 5′ end of the
primer that does not hybridize with the ribozyme can contain an
adapter sequence as well as a barcode sequence to encode reaction
conditions, for example, the presence or absence of a ligand.
Alternatively, if the cleaved and uncleaved ribozyme fragments are
separated (e.g. by gel electrophoresis) prior to reverse transcription, the
primer can contain a barcode sequence that distinguishes whether the
fragment was cleaved or not. There are several methods to attach an-
other adapter (and a barcode) sequence to the 3′ end of the newly
generated cDNAs. In the earlier work, splint oligonucleotide mediated
ligation was performed [22]. However, this requires careful optimiza-
tion of stoichiometry and reaction conditions. It is also not applicable to
systems where the ligation junction contains mutations. Another pos-
sibility is to exploit the template-switching activity of some reverse
transcriptases which allows attachment of an adapter sequence during
the reverse transcription reaction [17]. Again, reaction conditions must
be carefully optimized and the products need to be puriﬁed after re-
action. If there is suﬃcient length of constant sequence at the 3′ end of
the cDNAs, one can simply use PCR to both amplify the library and
attach the remaining adapter sequence. Furthermore, puriﬁcation and
PCR steps must be performed with care to minimize introduction of
biases that result in altered quantities of cleaved vs uncleaved frag-
ments. Overall, sequencing library construction strategy must be care-
fully planned according to the constraints (e.g. relative positions of
cleavage site and mutations, positions of constant and variable se-
quences) of each experiment.
Fig. 3. Ribozyme libraries characterized by se-
quencing. (A) Tandem aptazyme architecture.
Aptamer (red) and the pistol ribozyme (blue) struc-
tures are exclusive because formation of P1 is es-
sential for the aptamer structure but it interferes
with the ribozyme fold. Optimal P1 stability allows
switching between these two structures in the pre-
sence and absence of the aptamer ligand [23]. (B)
Stability of the P4 stem loop in an HDV-like ribo-
zyme was varied by randomizing 6 bases [24]. (For
interpretation of the references to colour in this
ﬁgure legend, the reader is referred to the web
version of this article.)
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After sequencing, the researcher can analyze the data by ﬁltering for
quality, removing adapter sequences, sorting by barcode sequences,
and enumerating cleaved and uncleaved reads of every mutant. Some of
the data processing can be performed using existing scripts and soft-
ware such as FASTX-Toolkit for quality ﬁltering and barcode splitting.
However, as ribozyme sequence and library design vary greatly from
one experiment to another, sorting and counting of ribozyme reaction
products are most conveniently executed using custom scripts such as
those written in Python or Perl. The fraction cleaved values obtained
should be validated by conventional biochemical assay. Several mu-
tants with varying catalytic activities should be cloned and individually
assayed by gel electrophoresis under the same condition as in the li-
brary preparation. Ribozyme activities of the mutants based on con-
ventional assay should be correlated with the fraction cleaved values
calculated from sequencing.
The reliability of activity data of individual ribozymes based on
sequencing depends on the number of sequencing reads which vary
statistically among mutants. Empirically, we have used a minimum of
∼200 reads per mutant as a guide to observe reasonable correlation
with gel analysis. Similarly, if detection limit and precision are critical,
sequence-based activity should be empirically checked against gel
analysis because errors or biases introduced during library preparation
and sequencing can become signiﬁcant. In the future, more rigorous
statistical analysis may be desirable to assist interpretation of the mu-
tate-and-sequence results.
4. Conclusion
High-throughput sequencing has had a profound impact on many
ﬁelds in life sciences. The technology is also useful for ribozyme re-
search because the genotype and the phenotype of ribozymes are en-
coded in the same molecule, the typical lengths of ribozymes are short,
and ribozymes can be easily converted to sequencing templates.
Mutate-select-and-sequence strategies allow more comprehensive cov-
erage of the large sequence space represented by pre- and post-selection
populations of ribozyme mutants, from which useful sequence-function
relationship knowledge can be extracted. Mutate-and-sequence ap-
proach, on the other hand, oﬀers more quantitative information on the
mutational landscape of ribozymes. Future advances in high-
throughput sequencing technologies such as direct single molecule RNA
sequencing should bring additional opportunities to study and engineer
ribozymes.
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